Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FN0F5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $85,314
Award facts
- Contract value 100% obligated
- $85,314.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 15, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units, with a firm fixed price ceiling value of $85,314.45 and an ultimate completion date of January 16, 2026. The award represents a non-competitive delivery order issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and federal healthcare systems worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains extensive experience fulfilling DLA medical supply chain requirements through open competition, demonstrating capability across diverse pharmaceutical products spanning multiple therapeutic domains including specialty medications and critical care materials. The delivery order contains no set-aside designation, reflecting the competitive nature of this procurement and the contractor's established position within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FN0F5?
SPE2DR26FN0F5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FN0F5 worth?
The government has obligated $85,314 on SPE2DR26FN0F5.
Is contract SPE2DR26FN0F5 an order under another contract?
Yes. SPE2DR26FN0F5 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0F5 competed?
The extent of competition for SPE2DR26FN0F5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award